1832 Asset Management’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-339,700
Closed -$97M 931
2023
Q2
$97M Sell
339,700
-45,800
-12% -$12.7M 0.12% 108
2023
Q1
$83.6M Buy
385,500
+56,100
+17% +$10.9M 0.12% 124
2022
Q4
$67.7M Sell
329,400
-196,100
-37% -$49.6M 0.11% 155
2022
Q3
$146M Buy
525,500
+116,700
+29% +$29.7M 0.27% 73
2022
Q2
$78.2M Buy
+408,800
New +$72.2M 0.14% 138
2021
Q4
Sell
-25,000
Closed -$5.17M 883
2021
Q3
$5.17M Buy
+25,000
New +$4.91M 0.01% 394

Other funds holding SWAV

1832 Asset Management's SWAV Position: Q3 2023 in Review

1832 Asset Management sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q3 2023, closing a stake of 339,700 shares — an estimated $97M sold.

1832 Asset Management first reported a position in SWAV in Q3 2021 and held it in 6 quarters. The position peaked at $146M in Q3 2022. 412 funds tracked by Wall St. Rank hold SWAV as of Q3 2023.

  • 1832 Asset Management reported no remaining Shockwave Medical, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • 1832 Asset Management sold 339,700 Shockwave Medical, Inc. Common Stock shares in Q3 2023, an estimated $97M.
  • 1832 Asset Management first reported a position in Shockwave Medical, Inc. Common Stock in Q3 2021 and held it in 6 quarters.
  • 1832 Asset Management's Shockwave Medical, Inc. Common Stock position peaked at $146M in Q3 2022.
  • 412 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q3 2023.

Based on 1832 Asset Management's 13F filing for Q3 2023, filed 13 Nov 2023.